91 related articles for article (PubMed ID: 5509035)
1. Clinical trials with CIBA 1507--Go, a new antihypertensive compound.
Misra RC; Gupta SK; Chuttani HK
J Assoc Physicians India; 1970 Dec; 18(12):979-82. PubMed ID: 5509035
[No Abstract] [Full Text] [Related]
2. A preliminary report on the clinical evaluation of a new antihypertensive--GO. 1507--CIBA.
Billimoria AR; Shah SJ; Mehta AJ; Anand MP; Kumar H
Indian Heart J; 1968 Oct; 20(4):406-22. PubMed ID: 4906150
[No Abstract] [Full Text] [Related]
3. [Urapidil in primary arterial hypertension].
Román O; Sudy E; Gac JC; Valenzuela MA
Rev Med Chil; 1987 Jul; 115(7):648-54. PubMed ID: 3331026
[No Abstract] [Full Text] [Related]
4. A preliminary report on the clinical evaluation of a new antihypertensive agent-Go 4416 CIBA.
Shah SJ; Billimoria AR; Haveliwala HK; Vibhakar BB; Kumar H
Indian Heart J; 1971 Apr; 23(2):164-7. PubMed ID: 5154112
[No Abstract] [Full Text] [Related]
5. Clinical safety and effectiveness of indorenate in essential hypertension.
Huape-Arreola S; Herrera-Abarca JE; Ruiz-Vega H; Hong E
Proc West Pharmacol Soc; 2002; 45():197-8. PubMed ID: 12434580
[No Abstract] [Full Text] [Related]
6. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
Kirch W; von Gizycki C
Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
[No Abstract] [Full Text] [Related]
7. Lofexidine, a new, antihypertensive imidazoline derivative. Clinical profile of action with single-drug treatment and in combination with hydrochlorothiazide.
Aigner A; Schmidt U
Arzneimittelforschung; 1982; 32(8a):976-83. PubMed ID: 6890373
[No Abstract] [Full Text] [Related]
8. [Clinical trial of a new antihypertensive agent].
Macrez C; Lescure J
Sem Hop; 1969 May; 45(24):1696-700. PubMed ID: 4308563
[No Abstract] [Full Text] [Related]
9. [Clinical studies on the treatment of hypertension using Disotat].
Fröhling P; Kautzsch G
Z Arztl Fortbild (Jena); 1977 Jan; 71(1):13-6. PubMed ID: 324148
[No Abstract] [Full Text] [Related]
10. Antihypertensive effect of prizidilol.
Jounela AJ; Honkala M; Huikuri H
Ann Clin Res; 1984; 16(3):176-80. PubMed ID: 6383185
[TBL] [Abstract][Full Text] [Related]
11. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
12. [Lipid metabolism in hypertensive therapy. Measurements of electrolytes, lipids and lipoproteins in blood of normal and hypertensive individuals during repeated administration of Ebrantil].
Mertz DP; Dittmann EC
MMW Munch Med Wochenschr; 1983 May; 125(18):389-91. PubMed ID: 6406877
[No Abstract] [Full Text] [Related]
13. Debrisoquin sulfate: a clinical evaluation of a new antihypertensive agent.
Blechman M; Sokol C; Moser M
Curr Ther Res Clin Exp; 1969 Feb; 11(2):71-6. PubMed ID: 4975816
[No Abstract] [Full Text] [Related]
14. [Treatment of hypertension with urapidil].
Fetkovská N; Dzúrik R
Cas Lek Cesk; 1985 Oct; 124(41-42):1292-5. PubMed ID: 3902242
[No Abstract] [Full Text] [Related]
15. [Treatment of hypertensive crisis with ebrantil (urapidil)].
Mleczko-Nycz Z; Kokot F
Wiad Lek; 1984 Jun; 37(11):817-20. PubMed ID: 6390979
[No Abstract] [Full Text] [Related]
16. [A new antihypertensive agent used in a clinical setting].
Wetzels E; Raschig A; Kaiser HJ
Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
[TBL] [Abstract][Full Text] [Related]
17. [Comparison between timolol maleate and alphamethyldopa in longterm treatment of essential hypertension (author's transl)].
G Ital Cardiol; 1981; 11(12):2110-6. PubMed ID: 7346307
[No Abstract] [Full Text] [Related]
18. Clinical assessment of the new antihypertensive Compound--1029 (Vatensol)--Guanoclor.
Mehta AB; Biswas AK; Pinto IJ; Sheth UK
Indian Heart J; 1967 Oct; 19(4):322-8. PubMed ID: 4870898
[No Abstract] [Full Text] [Related]
19. [Effect of prolonged treatment with 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on renal hemodynamics in arterial hypertension].
Ludwig H
Arzneimittelforschung; 1968 May; 18(5):600-4. PubMed ID: 5755891
[No Abstract] [Full Text] [Related]
20. [Clinical experiences with a new antihypertensive agent].
Lieb W; Ridders K
Arzneimittelforschung; 1966 Dec; 16(12):1610-5. PubMed ID: 6014793
[No Abstract] [Full Text] [Related]
[Next] [New Search]
